RENEWAL is designed to offer hope and comfort to people suffering from mental health disorders or addiction disorders, and support to the people who love them. Our approach is based on respect for the dignity of the people we serve and the belief that through a faith-based program, life-changing results are possible.

RENEWAL: Christian Treatment and Recovery is an optional treatment supplement available through Brookhaven Hospital in Tulsa, Oklahoma. At Brookhaven, we understand that when you are suffering from an eating disorder, a personality disorder, a behavioral health disorder or chemical dependency, life can seem utterly hopeless. It can cause Christians to feel abandoned and distant from God. However, by strengthening your spirituality, in conjunction with our professional medical services, you can experience results that you never thought were possible.

RENEWAL is based on the belief in:

God who created us and loves us (Genesis 1:26)
Jesus Christ who redeems us (Isaiah 53:5)
The Holy Spirit who guides us (Acts 1:8)

When you participate in RENEWAL, you’re part of something much bigger than yourself. Brookhaven clients receive expert care from our team of mental professionals. Treatment is solution-focused and success-oriented. Our goal is to minimize symptoms, help individuals address life problems and live fulfilling lives. Sometimes healing requires a helping hand. We’re here to provide the guidance and support you need to recover.

Christian Care
The RENEWAL program at Brookhaven Hospital incorporates your faith into the recovery process in order to address your physical, mental and spiritual needs

Christian Drug Rehab
Our program provides a nurturing atmosphere that allows you to sober up and strengthen your bond with God.

Christian Bulimia Treatment
Individuals with bulimia alternate between compulsive binge eating and purging. Without treatment bulimia can be deadly. Brookhaven’s RENEWAL program can offer medical, psychological and faith-based eating disorder treatments.

PTSD Treatment
Post-traumatic stress disorder (PTSD) occurs after a traumatic event. Without getting proper help it can be debilitating. Strengthening your faith can help you confront the past and form a brighter future.

Christian Healing
When you are part of the RENEWAL program, you are part of something bigger than yourself. You are part of a support system based on professional medical care as well as spiritual guidance.

Compulsive Overeating
When you suffer from compulsive overeating disorder, your meals and your life can seem out of control. Take a faith-based approach to your eating disorder treatment at RENEWAL.

Anorexia Treatment
Anorexia is characterized by the restriction of food intake and the refusal to maintain a healthy body weight. Without getting help, anorexia can be life-threatening.

Bipolar Disorder Treatment
Everyone experiences ups and downs, but when you’re suffering from bipolar disorder life can seem out of control. Brookhaven’s RENEWAL program incorporates your spirituality into an advanced behavioral health program.

OCD Treatment
Obsessive-compulsive disorder (OCD) can fill your life with uncontrollable thoughts (obsessions) and rituals (compulsions) and stand in the way of relationships and your career.

New drug seeking approval from the FDA effective in relieving chronic pain

Share

A new drug seeking approval from the FDA, ALO-01 (Embeda), has been proven effective in relieving chronic pain. According to findings from research revealed at the annual clinical meeting of the American Academy of Pain Management, 72.5% of patients responded to the morphine drug with a built in anti-abuse factor, compared to 57.8% of those taking placebo. The researchers defined response as more than 30% improvement in pain intensity score from baseline. The research team reported that the drug was accepted for a priority review from the FDA on Sept. 2. According to Joseph Stauffer, D.O., of Alpharma Pharmaceuticals, if the drug is approved it would be “… the first opioid medicine to provide a pharmacologic abuse-deterrent feature while effectively treating patients with chronic pain.” The following is an excerpt of an article from Medpage Today that reviews findings about the new drug:

To avoid that possibility, Dr. Stauffer said, ALO-01 capsules contain polymer-coated extended-release pellets of morphine sulfate and each has a core of naltrexone (Depade, ReVia), an opioid antagonist.

The idea is that the naltrexone will kick in and reduce the euphoric effects of morphine if the capsule is crushed or chewed. Otherwise, the naltrexone is intended to pass through the body without “clinically meaningful release or accumulation,” according to a company statement.

In the current study, the researchers enrolled 344 adult patients with moderate to severe pain from osteoarthritis of the hip or knee. After up to 14 days of screening and washout, they were titrated to effective pain management levels with ALO-01 in an open-label fashion.

Volunteers were then randomized in a double-blind fashion to either ALO-01 capsules or placebo for 12 weeks.

The main endpoint was mean change in weekly average pain diary score from randomization to the 12-week visit. Responder rate was a secondary efficacy endpoint.

The researchers analyzed the usual adverse events, but also evaluated the possibility of opioid withdrawal using the Clinical Opiate Withdrawal Scale — a clinician assessment of objective signs of withdrawal — and the Subjective Opiate Withdrawal Scale, a self-administered instrument.

Click here to read the rest of this article from Medpage Today

No comments yet.

Leave a Reply